New Leaf Venture Partners, L.L.C.

Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

Symbol: CRNX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share (the "Shares")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	14%	0%	$5,872,650	141,000	0		$41.65	Q3 2025
30 Jun 2025	12%	0%	$4,055,160	141,000	0		$28.76	Q2 2025
31 Mar 2025	11%	0%	$4,729,140	141,000	0		$33.54	Q1 2025
31 Dec 2024	9.6%	0%	$7,209,330	141,000	0		$51.13	Q4 2024
30 Sep 2024	7.4%	0%	$7,205,100	141,000	0		$51.10	Q3 2024
30 Jun 2024	7.7%	0%	$6,315,390	141,000	0		$44.79	Q2 2024
31 Mar 2024	5.8%	0%	$6,600,210	141,000	0		$46.81	Q1 2024
31 Dec 2023	4%	0%	$5,016,780	141,000	0		$35.58	Q4 2023
30 Sep 2023	5.4%	0%	$4,193,340	141,000	0		$29.74	Q3 2023
30 Jun 2023	2.2%	0%	$2,540,820	141,000	0		$18.02	Q2 2023
31 Mar 2023	1.9%	0%	$2,264,460	141,000	0		$16.06	Q1 2023
31 Dec 2022	1.9%	0%	$2,580,300	141,000	0		$18.30	Q4 2022
30 Sep 2022	1.7%	0%	$2,769,000	141,000	0		$19.64	Q3 2022
30 Jun 2022	1.7%	0%	$2,630,000	141,000	0		$18.65	Q2 2022
31 Mar 2022	1.5%	0%	$3,095,000	141,000	0		$21.95	Q1 2022
31 Dec 2021	1.5%	0%	$4,006,000	141,000	0		$28.41	Q4 2021
30 Sep 2021	0.86%	0%	$2,968,000	141,000	0		$21.05	Q3 2021
30 Jun 2021		0%	$44,282,000	141,000	0		$314.06 ^*	Q2 2021
31 Mar 2021	0.5%	0%	$2,154,000	141,000	0		$15.28	Q1 2021
31 Dec 2020	0.46%	0%	$1,990,000	141,000	0		$14.11	Q4 2020
30 Sep 2020	0.89%	0%	$2,209,000	141,000	0		$15.67	Q3 2020
30 Jun 2020	0.71%	0%	$2,470,000	141,000	0		$17.52	Q2 2020
31 Mar 2020	0.62%	0%	$2,073,000	141,000	0		$14.70	Q1 2020
31 Dec 2019	0.9%	0%	$3,538,000	141,000	0		$25.09	Q4 2019
30 Sep 2019	0.64%	-0.12%	$2,121,000	141,000	-26,700	-16%	$15.04	Q3 2019
30 Jun 2019	1.1%	0%	$4,193,000	167,700	0		$25.00	Q2 2019
31 Mar 2019	1%	0%	$3,817,000	167,700	0		$22.76	Q1 2019
31 Dec 2018	1.4%	0%	$5,029,000	167,700	0		$29.99	Q4 2018
30 Sep 2018	0.87%	+0.87%	$4,805,000	167,700	+167,700	NEW	$28.65	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.